Tolmar

FENSOLVI - Cost

Last Updated: April 1st, 2024

HCPCS:

J1951

HCPCS Code Descriptor:

Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg

Medicare Payment Limit:

The FENSOLVI Medicare Payment Limit is $131.705

Average Sale Price:

FENSOLVI ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The FENSOLVI Medicare Co-insurance percentage is 20%. FENSOLVI's Medicare Co-insurance amount is $26.34 per HCPCS unit.

APC Code:

The Fensolvi APC Code is: 9419

APC Payment Limit:

The APC Payment Limit for FENSOLVI is available. Login to view.

Fensolvi Cost Information:

Fensolvi’s HCPCS Code: J1951 was approved under the 505(b)(2) pathway and made effective on July 1st, 2021. Fensolvi’s active ingredient is leuprolide acetate, which currently has five unique HCPCS Codes; four of which were approved under the 505(b)(2) pathway. Fensolvi is Tolmar’s unique HCPCS for leuprolide acetate. Since its release in July of 2021, Fensolvi has taken annual increases to its list pricing and its ASP has remained steady. Fensolvi’s ASP is close to its WAC indicating a lack of significant discounting.

ACCESS PRICING AND MORE BY REGISTERING

Fensolvi’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Fensolvi’s average wholesale price (AWP) information was last updated on:
January 1, 2024